EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Novel Adiponectin Resistin indices and ratios predict increased cardiovascular risk in patients with type 2 diabetes mellitus

Syed S Habib, Thamir Al-Khlaiwi, Muhammad A Butt, Syed M Habib, Huthayfah Al-Khliwi, Khalid Al-Regaiey

Journal of the Saudi Heart Association · 25.04.2023 · 35 (1) · 59-65

DOI: 10.37616/2212-5043.1332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Saudi Heart Association, online erschienen am 25.04.2023. Verfasst von Syed S Habib und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Adiponectin and resistin are adipokines involved in insulin resistance, glucometabolic control and adiposity. There is evidence that hypoadiponectinemia and hyperresistinemia are associated with cardiovascular disease. Whether the ratio of Adiponectin-Resistin (AR) and Insulin Resistance Adiponectin-Resistin (IRAR) indices can be used as non-invasive biomarker of cardiovascular disease needs more attention. Therefore, the aim of this study was to assess the relationships of AR and IRAR indices with adiposity, glucometabolic control and cardiovascular risk incurred by high-sensitivity C-reactive protein (hsCRP) in healthy subjects and patients with Type 2 Diabetes Mellitus.

Methods

This observational case control study was conducted in the Department of Physiology and Medicine, King Saud University, Riyadh. A total of 191 (control=84 and diabetic=107) subjects were recruited. Body composition was assessed by bioelectrical impendence analyzer (BIA). Fasting blood samples were analyzed for glucose, glycosylated hemoglobin (HbA1c), high-sensitivity C-reactive protein (hsCRP), lipid profile, adiponectin, and resistin levels. The AR and IRAR indices were determined by formulas.

Results

Serum adiponectin levels were significantly lower in diabetics compared to control (95.45 ± 39.27 ng/ml vs 146.64 ± 56.36 ng/ml, p

Schlagwörter

Stichwörter der Autor:innen

Adiponectin-resistin indexCardiovascular riskDiabetes mellitusHigh-sensitivity C-Reactive proteinInsulin resistance adiponectin-resistin index

Autor:innen und Institutionen

  • Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Department of Family Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Sulaiman Alrajhi University Al Bukayriah, Saudi Arabia.

Zitieren

APA

Habib, S. S., Al-Khlaiwi, T., Butt, M. A., Habib, S. M., Al-Khliwi, H., & Al-Regaiey, K. (2023). Novel Adiponectin Resistin indices and ratios predict increased cardiovascular risk in patients with type 2 diabetes mellitus. Journal of the Saudi Heart Association, 35(1), 59-65. https://doi.org/10.37616/2212-5043.1332

Vancouver

Habib SS, Al-Khlaiwi T, Butt MA, Habib SM, Al-Khliwi H, Al-Regaiey K. Novel Adiponectin Resistin indices and ratios predict increased cardiovascular risk in patients with type 2 diabetes mellitus. Journal of the Saudi Heart Association. 2023;35(1):59-65. doi:10.37616/2212-5043.1332

BibTeX
@article{Habib2023,
  author = {Habib, Syed S and Al-Khlaiwi, Thamir and Butt, Muhammad A and Habib, Syed M and Al-Khliwi, Huthayfah and Al-Regaiey, Khalid},
  title = {Novel Adiponectin Resistin indices and ratios predict increased cardiovascular risk in patients with type 2 diabetes mellitus},
  journal = {Journal of the Saudi Heart Association},
  year = {2023},
  volume = {35},
  number = {1},
  pages = {59--65},
  doi = {10.37616/2212-5043.1332}
}
Kostenlos starten →